Requirements for human‐induced pluripotent stem cells

Requirements for human‐induced pluripotent stem cells

‘Requirements for Human‐Induced Pluripotent Stem Cells’ is the first set of guidelines on human‐induced pluripotent stem cells in China, jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research. This standard specifies the technical requirements, test methods, and i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell proliferation 2022-04, Vol.55 (4), p.e13182-n/a
Hauptverfasser: Zhang, Ying, Wei, Jun, Cao, Jiani, Zhang, Kehua, Peng, Yaojin, Deng, Hongkui, Kang, Jiuhong, Pan, Guangjin, Zhang, Yong, Fu, Boqiang, Hu, Shijun, Na, Jie, Liu, Yan, Wang, Lei, Liang, Lingmin, Zhu, Huanxin, Zhang, Yu, Jin, Zi‐Bing, Hao, Jie, Ma, Aijin, Zhao, Tongbiao, Yu, Junying
Format: Artikel
Sprache:eng
Schlagworte:
Acquired immune deficiency syndrome
AIDS
Cell Differentiation
China
Epstein-Barr virus
Guidelines
Hepatitis B
Hepatitis C
HIV
Human immunodeficiency virus
Human wastes
Humans
human‐induced pluripotent stem cells
Induced Pluripotent Stem Cells
Manufacturing
Medical laboratories
Microorganisms
Morphology
Packaging
Pluripotency
Process controls
Quality control
Reagents
Standardization
Stem cells
Teaching methods
Test methods
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:‘Requirements for Human‐Induced Pluripotent Stem Cells’ is the first set of guidelines on human‐induced pluripotent stem cells in China, jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research. This standard specifies the technical requirements, test methods, and instructions for use, labeling, packaging, storage, transportation, and waste handling for human‐induced pluripotent stem cells, which apply to the production and quality control of human‐induced pluripotent stem cells. It was released by the Chinese Society for Cell Biology on 9 January 2021 and came into effect on 9 April 2021. We hope that the publication of these guidelines will promote institutional establishment, acceptance, and execution of proper protocols and accelerate the international standardization of human‐induced pluripotent stem cells for applications.
ISSN:0960-7722
1365-2184
DOI:10.1111/cpr.13182